Showing results (371-380 of 389) with videos related to

Sort By:
Pageof 39
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|January 12, 2026
Underlying Tremor Improvement with Consistent Use of Transcutaneous Afferent Patterned Stimulation in Patients with Essential TremorStuart H Isaacson, Elizabeth Peckham, Winona Tse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiationJoshua A Bauer, A Bapsi Chakravarthy, Jennifer M Rosenbluth, et al.
The Lancet. Respiratory Medicine|November 7, 2022
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsNicole Mayer-Hamblett, Felix Ratjen, Renee Russell, et al.
Cell Metabolism|February 26, 2019
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione DepletionIsaac S Harris, Jennifer E Endress, Jonathan L Coloff, et al.
Nature Biotechnology|December 18, 2019
A large peptidome dataset improves HLA class I epitope prediction across most of the human populationSiranush Sarkizova, Susan Klaeger, Phuong M Le, et al.
Nature Materials|March 11, 2026
Stress-relaxing granular bioprinting materials enable complex and uniform organoid self-organizationAustin J Graham, Michelle W L Khoo, Vasudha Srivastava, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissueNadine Goldhammer, Marin Bont, Shruti Warhadpande, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2017
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67Bojana Jovanović, Ingrid A Mayer, Erica L Mayer, et al.
The Lancet. Respiratory Medicine|May 20, 2014
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trialEitan Kerem, Michael W Konstan, Kris De Boeck, et al.
Journal of Hospital Medicine|November 3, 2022
Implementation of the I-PASS handoff program in diverse clinical environments: A multicenter prospective effectiveness implementation studyAmy J Starmer, Nancy D Spector, Jennifer K O'Toole, et al.
Pageof 39